| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 109,969 | $5.20 | $572,020.51 | -50.5% | |
| Jun 5, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 20,831 | $5.15 | $107,356.26 | -16.2% | |
| Jun 4, 2018 | 10x Fund, L.P.85 | - | Sell | 50,000 | $5.12 | $256,080.93 | -0.8% | |
| Jun 4, 2018 | Czirr James C | - | Sell | 50,000 | $5.12 | $256,080.93 | -0.8% | |
| Jun 1, 2018 | Shlevin Harold H.89 | Chief Operating Officer | Sale+OE | 119,200 | $5.06 | $602,920.00 | -52.5% | |
| May 31, 2018 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 46,651 | $5.00 | $233,255.00 | -97.4% | |
| Apr 16, 2018 | Zucconi Theodore Daniel | Director | Sale+OE | 4,000 | $3.58 | $14,320.00 | -78.7% | |
| Apr 4, 2018 | Callicutt Jack W62 | Chief Financial Officer | Sale+OE | 3,349 | $5.00 | $16,745.00 | -72.7% | |
| Feb 1, 2018 | Freeman Kevin D57 | Director | Buy | 2,000 | $4.10 | $8,191.00 | +14.3% | |
| Feb 1, 2018 | Freeman Kevin D57 | Director | Buy | 2,000 | $4.10 | $8,191.00 | +14.3% |